On March 4, 2024, NewGLAB Pharma CO.,LTD closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,383 KRW | -27.44% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 48.05M | |
+17.65% | 1.88B | |
-15.69% | 1.12B | |
+13.70% | 849M | |
+58.15% | 805M | |
-10.26% | 790M | |
+49.47% | 705M | |
-28.90% | 364M | |
-10.17% | 280M | |
+19.19% | 101M |
- Stock Market
- Equities
- A214870 Stock
- News NewGLAB Pharma CO.,LTD
- NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors